COVID-19 updates, including vaccine information, for our patients and visitors Learn More

Menu
Search

PBS Program on Memory Features UCSD Faculty Experts

 

November 17, 2005  |  

The upcoming PBS "Scientific American Frontiers" program on memory, called “Don’t Forget,” features several UCSD School of Medicine faculty members.

Program host Alan Alda visited San Diego last fall to interview a number of San Diego experts on memory loss. The program, airing Tuesday night, May 11 at 10 p.m. on KPBS-TV, focuses on the work of Dr. Larry Squire and Dr. Igor Grant of the UCSD School of Medicine and Veterans Affairs Medical Center Department of Psychiatry, and Dr. Mark Tuszynski of the UCSD School of Medicine Department of Neurosciences.

The segment about Dr. Tuszynski’s research will feature a San Diego woman who participated in his recent clinical trial, which tested the safety of gene therapy as an approach to slowing the cell degeneration that underlies memory loss in Alzheimer’s disease patients. Dr. Squire's work with patient "E.P." whose hippocampus was destroyed by a viral infection will be discussed; and a segment on the families of Alzheimer’s patients will include Dr. Grant's observations about caregiver stress.

In addition to the Tuesday night premier, the program will air Wednesday, May 12 at 2 a.m. and 5 a.m., and Sunday May 16 at 5 a.m. KPBS-TV can be seen on Channel 15/Cable Channel 11.

News Media Contact
Leslie Franz
619-543-6163




Media Contact

Share This Article


Related News

3/3/2021
UC San Diego School of Medicine researchers develop an automated process to test city sewage for SARS-CoV-2, allowing them to forecast the region’s COVID-19 caseload one to two weeks ahead of clinical ...
3/2/2021
Researchers at UC San Diego School of Medicine and elsewhere have identified a new drug that could prevent AD by modulating, rather than inhibiting, a key enzyme involved in forming amyloid plaques.
3/2/2021
Researchers at UC San Diego Health see a possible way to detect heart disease through the eye.
3/1/2021
A repurposed drug used to treat arthritis did not significantly improve the outcomes of patients with severe COVID-19 pneumonia. Tocilizumab did not significantly improve clinical status or mortality ...



Follow Us